Akoya Biosciences: Q2 Earnings Insights
Akoya Biosciences (NASDAQ:AKYA) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
A Preview Of Akoya Biosciences’s Earnings
Akoya Biosciences (NASDAQ:AKYA) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement.
Analysts estimate that Akoya Biosciences will report an earnings per share (EPS) of $-0.37.
Akoya Biosciences To Partner With Acrivon Therapeutics For The Clinical Development Of Acrivon’s Proprietary OncoSignature Test Into A Companion Diagnostic
Akoya Biosciences, Inc., (NASDAQ:AKYA), The Spatial Biology Company®, and Acrivon Therapeutics, Inc., a clinical-stage oncology therapeutics company with proprietary technologies driving a new era of precision-based
Piper Sandler Maintains Overweight on Akoya Biosciences, Lowers Price Target to $14
Piper Sandler analyst David Westenberg maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price target from $18 to $14.
Akoya Biosciences Q1 EPS $(0.44) Misses $(0.39) Estimate, Sales $16.90M Beat $14.93M Estimate
Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.39) by 12.82 percent. This is a 87.57 percent increase over losses of $(3.54) per share
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Akoya Biosciences Earnings Preview
Akoya Biosciences (NASDAQ:AKYA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement.
Analysts estimate that Akoya Biosciences will report an earnings per share (EPS) of $-0.39.